US 11167012
Peptide inhibition of CCR3-mediated diseases or conditions
granted A61KA61K38/00A61K38/195
Quick answer
US patent 11167012 (Peptide inhibition of CCR3-mediated diseases or conditions) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/00, A61K38/195, A61K47/10, A61K47/6813